News

Nuvo Announces Axia Women’s Health as First in the U.S. to Conduct FDA-cleared Remote Fetal Wellness Checks

Earlier today Nuvo announced today that for the first time, expectant mothers in the U.S. will have access to INVU, a remote monitoring platform that enables virtual fetal wellness check-ins with their doctors from any location. INVU, an FDA-cleared, prescription-initiated device will be accessible through a commercialization agreement between Nuvo and Axia Women’s Health, a women’s health network of more than 400 providers…

Vizgen Announces U.S. Accelerator Lab to Advance Pharma R&D

Vizgen, a life sciences company developing the next generation of in situ single-cell genomics, today announced the launch of its Pharma Accelerator Lab in response to high demand from leading pharmaceutical companies who are increasingly turning to single-cell and spatial transcriptomics solutions to accelerate their drug development pipelines. “Today’s pharma R&D leaders are benefiting from spatial omics approaches that unlock unprecedented insight…

Hologic to Acquire Biotheranostics, a Leader in Molecular Tests for Breast and Metastatic Cancers

Hologic announced today that it has agreed to acquire Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments. “Acquiring Biotheranostics enables us to jump-start our entry into a large, fast-growing oncology adjacency that fits perfectly with our broader corporate focus and passion…

FPA Women’s Health Adopts NextGen Healthcare’s Patient Experience Platform to Ensure Continuity of Care During COVID-19

NextGen Healthcare, a provider of ambulatory-focused technology solutions, announced that its integrated NextGen Patient Experience Platform has been adopted by FPA Women’s Health, a mid-sized specialty medical group focused on women’s healthcare, to provide continuity of care during the COVID-19 pandemic. Since the practice’s inception in 1969, Family Planning Associates Medical Group, now FPA Women’s Health, has been providing the highest standard of medical care…

Volpara Health Announces Two New Studies to Evaluate the Impact of Their AI-Powered Software in Breast Cancer Risk Assessment

Earlier this week Volpara Health announced two new research studies using their AI-powered software to score breast density objectively and consistently to evaluate its impact in mammography and breast cancer risk assessment. Volpara Density software uses a combination of x-ray physics and machine learning to generate an accurate volumetric measure of breast composition and remains the density measurement tool of choice for…

Northwestern Medicine Opens Comprehensive Program for Vulvar and Vaginal Health

Northwestern Medicine is now offering a specialized clinic for women with complex vulvar and vaginal conditions. Led by Rajal Patel, MD, the Comprehensive Program for Vulvar and Vaginal Health is the latest clinic integrated into the Northwestern Medicine Center for Sexual Health and Menopause. “As gynecologists we are trained to look at the inside but many women’s problems originate from the external, not internal, genitalia,”…

OvaryIt Launches Telehealth Platform to Help Women Choose the Right Contraception

Earlier this week OvaryIt announced the launch of its OvaryIt platform to provide telehealth solutions for women seeking focused specialty care related to hormonal and non-hormonal contraception. Using OvaryIt’s network of independent physicians and its proprietary platform (using the latest cryptographic safety and privacy features), women can safely and confidently engage through a telehealth interface.  From the moment you first log in,…

Rhia Ventures Invests in OCON Healthcare’s Ballerine, the First 3D Spherical Copper Intrauterine Contraceptive

Rhia Ventures has invested in Israel-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUB (Intrauterine Ball). Ballerine’s unique shape reduces irritation to the endometrium with fewer malpositions and perforations, which are significant drawbacks associated with current T-shaped IUDs. The financing will also help expand Phase II clinical trials for OCON’s SEAD product, which offers point-of-care…